3 entities actively seeking solutions — right now.

Pursuit detects live formulary signals from KS, AK, and NV health agencies reviewing Pfizer products—three of thousands in market. Win before RFPs drop; real-time intent beats formal procurement every time.

See the Full Platform

See 3 opportunities ↓

SLED entities monitored

110K+

Documents processed monthly

3M+

Before RFPs drop

6–18mo

Earlier than the competition

92 days

From 110K+ entities monitored

Pre-RFP signals for

<div class='ecard'><div class='ecard-header'><div><div class='ecard-name'>Department of Health & Environment</div><div class='ecard-meta'>County Government · KS</div></div><div class='ecard-header-right'><span class='badge badge-active'>Active Signal</span></div></div><div class='ecard-signals'><div class='signal-item'><div class='signal-title'>Preferred Drug List Committee discusses formulary decisions for state health programs</div><div class='signal-body-text'>The Kansas Department of Health and Environment's Preferred Drug List Committee is actively discussing formulary decisions that directly impact drug procurement for state-funded health programs. This initiative is relevant for providers of monoclonal antibody-based cancer therapies seeking to influence state formulary coverage and reimbursement decisions. No RFP has been issued; this is pre-solicitation intelligence.</div></div><div class='signal-item'><div class='signal-title'>State drug procurement decisions impact cancer therapy coverage options</div><div class='signal-body-text'>The Department of Health & Environment's formulary decisions directly control budget allocation and reimbursement rates for state-funded health programs, creating significant cost implications for therapy adoption. Monoclonal antibody providers that engage early in this committee process can shape cost-effectiveness criteria and secure favorable pricing tiers before procurement budgets are finalized.</div></div></div><div class='ecard-contacts'><div class='ecard-contacts-label'>Key Contacts · 5 verified by Pursuit</div><div class='contact-list'><div class='contact-row'><div class='contact-info'><span class='contact-name'>Kerri Yocum</span><span class='contact-title'>Contractual Services Unit Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Jessie Piper</span><span class='contact-title'>Co-bureau Director</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Karen Perez</span><span class='contact-title'>Program Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Lisa Edgerton-johnston</span><span class='contact-title'>Tb/sti/hiv/viral Hepatitis Consultation and Education Deputy Section Chief and 340b Program Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Christina Ferguson</span><span class='contact-title'>Kmms Operations Senior Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div></div></div><div class='ecard-footer'><a class='ecard-source-link' href='https://www.kdhe.ks.gov/DocumentCenter/View/55385/Agenda-January-2026--PDL?bidId=#page=1' target='_blank'>View source · 2026-01-20</a><span class='ecard-timing'>⏱ Pre-RFP — no solicitation issued</span></div></div> <div class='ecard'><div class='ecard-header'><div><div class='ecard-name'>Department of Health</div><div class='ecard-meta'>County Government · AK</div></div><div class='ecard-header-right'><span class='badge badge-active'>Active Signal</span></div></div><div class='ecard-signals'><div class='signal-item'><div class='signal-title'>Pharmacy and Therapeutics Committee inviting manufacturers to submit clinical material</div><div class='signal-body-text'>The State of Alaska's Department of Health is actively reviewing its Preferred Drug List and inviting pharmaceutical manufacturers to submit clinical materials for consideration by the Pharmacy and Therapeutics Committee. This initiative directly impacts sellers of monoclonal antibody-based cancer therapies, as inclusion on the preferred list is critical for market access and reimbursement. No RFP has been issued; this is pre-solicitation intelligence.</div></div><div class='signal-item'><div class='signal-title'>Department of Health evaluating monoclonal antibody cancer therapy options</div><div class='signal-body-text'>The Department of Health's January 2026 committee meeting signals imminent budget allocation decisions for cancer therapy coverage, creating time-sensitive opportunities for manufacturers to influence formulary positioning before fiscal commitments lock in. Early submission of clinical materials directly shapes reimbursement rates and patient access pathways, translating to revenue predictability and market share protection.</div></div></div><div class='ecard-contacts'><div class='ecard-contacts-label'>Key Contacts · 5 verified by Pursuit</div><div class='contact-list'><div class='contact-row'><div class='contact-info'><span class='contact-name'>Christal Hays</span><span class='contact-title'>Project Coordinator/mac-bac Department Facilitator</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Tricia Skitt</span><span class='contact-title'>Medicaid Operations Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Hilary Porter</span><span class='contact-title'>Grants and Procurement Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Jason Grove</span><span class='contact-title'>Contracts Manager</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div><div class='contact-row'><div class='contact-info'><span class='contact-name'>Emily Beaulieu</span><span class='contact-title'>Title Xix Administrator</span></div><div class='contact-data-hints'><span class='data-hint'>Email</span><span class='data-hint'>Phone</span></div></div></div></div><div class='ecard-footer'><a class='ecard-source-link' href='https://health.alaska.gov/media/cd2phz1a/ak-medicaid-pt-january-2026-notice.pdf#page=1' target='_blank'>View source · 2026-01-16</a><span class='ecard-timing'>⏱ Pre-RFP — no solicitation issued</span></div></div>

Why needs Pursuit

92 days

Earlier to every deal

Pursuit customers engage an average of 92 days before the competition finds the same opportunity — giving Keeper Security's team time to shape the deal and show up as the trusted partner before any RFP is written.

2.5M

Documents processed monthly

Pursuit reads 2.5 million government documents monthly — meeting minutes, strategic plans, budget filings, and FOIA records — surfacing the signals that matter to Keeper Security's ICP before they become public solicitations.

73%

Of deals are decided before the RFP drops

By the time a formal solicitation is published, the winning vendor is usually already in the room. Pursuit gets your team there first — with the context, contacts, and credibility to shape the deal before anyone else knows it exists.

SCHEDULE DEMO

See Pfizer's full pipeline in Pursuit.

These three are a sample of what Pursuit surfaces for Pfizer across 110,000+ entities matched to your ICP. Book time to see your full ICP‑matched opportunity list — with contacts, signals, and source documents for every account.

TRUSTED BY